Skip to main content
$40.29 -$0.98 (-2.4%)

04:00 PM EDT on 10/26/21

VIR Biotechnology (NASDAQ:VIR)

CAPS Rating: 3 out of 5

Current Price $40.29 Mkt Cap $5.4B
Open $41.35 P/E Ratio 0.00
Prev. Close $40.29 Div. (Yield) $0.00 (0.0%)
Daily Range $39.70 - $41.37 Volume 450,732
52-Wk Range $25.31 - $141.01 Avg. Daily Vol. 890,533

Caps

How do you think NASDAQ:VIR will perform against the market?

Add Stock to CAPS Watchlist

All Players

18 Outperform
1 Underperform
 

All-Star Players

5 Outperform
1 Underperform
 

Wall Street

0 Outperform
0 Underperform
 

Top NASDAQ:VIR Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

Bigsef77 (69.17)
Submitted January 27, 2020

Vir Biotech up 21% on coronavirus buying frenzyJan. 27, 2020 10:19 AM ET|About: Vir Biotechnology, Inc. (VIR)|By: Douglas W. House, SA News Editor Thinly traded Vir Biotechnology (VIR +20.9%) is up up on almost a 4x surge in volume, albeit a… More

Top Bear Pitch

There are no pitches that meet the Top Bear criteria. Explain

If this upsets you, start recommending pitches below!

NASDAQ:VIR VS S&P 500 (SPY)

NASDAQ:VIR Summary

Fools bullish on NASDAQ:VIR are also bullish on:

Fools bearish on NASDAQ:VIR are also bearish on:

Recent Community Commentary

Read the most recent pitches from players about VIR.

Recs

0
Member Avatar TMFAdriaCimino (22.93) Submitted: 6/1/2021 6:48:19 AM : Outperform Start Price: $42.73 NASDAQ:VIR Score: -13.62

Vir should benefit from its first commercialized product, its antibody treatment for covid. It may stand out because so far the product works against all variants of concern.

Recs

1
Member Avatar Bigsef77 (69.17) Submitted: 1/27/2020 1:40:44 PM : Outperform Start Price: $13.08 NASDAQ:VIR Score: +160.56

Vir Biotech up 21% on coronavirus buying frenzy
Jan. 27, 2020 10:19 AM ET|About: Vir Biotechnology, Inc. (VIR)|By: Douglas W. House, SA News Editor
Thinly traded Vir Biotechnology (VIR +20.9%) is up up on almost a 4x surge in volume, albeit a relatively modest 514K shares, as the animal spirits continue to sweep up companies that may be positioned to benefit from the coronavirus outbreak.

The company has four technology platforms that it is leveraging to develop treatments for infectious diseases, including influenza and tuberculosis.

Leaderboard

Find the members with the highest scoring picks in VIR.

Score Leader

slnoutperform

slnoutperform (21.81) Score: +261.68

The Score Leader is the player with the highest score across all their picks in VIR.

Top
Pick
Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
Index
Gain
Score Commentary
Bigsef77 69.17 11/13/2019 6/28/2021 Outperform 5Y $13.08 +208.03% +47.47% +160.56 1 Comment
TMFSaintCroix 99.74 11/1/2019 Outperform 5Y $14.10 +185.74% +49.55% +136.19 0 Comment
TheFall2021 85.02 1/21/2021 Underperform 5Y $43.03 -6.37% +18.51% +24.88 0 Comment
77lucky 51.87 10/6/2021 Outperform 5Y $34.24 +17.68% +6.11% +11.57 0 Comment
Espi < 20 7/15/2021 Outperform 1Y $36.28 +11.06% +4.87% +6.18 0 Comment
MoSteele 40.14 12/4/2020 Outperform 3Y $31.49 +27.95% +23.32% +4.63 0 Comment
LEOTHELIONRAWW 24.60 1/14/2021 Outperform 5Y $35.86 +12.35% +19.87% -7.52 0 Comment
glenn12345 28.67 9/28/2021 Outperform 5Y $43.00 -6.30% +5.04% -11.34 0 Comment
TMFAdriaCimino 22.93 6/1/2021 Outperform NS $42.73 -5.71% +7.91% -13.62 1 Comment
LOSBW 79.03 6/11/2021 Outperform 5Y $46.28 -12.94% +7.50% -20.44 0 Comment

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

There are no Wall Street tracker picks for VIR.